Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00899496 · ClinicalTrials.gov registry record
Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- 54
- Enrollment target
NCT00899496 is a clinical trial that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 54 participants.
The verdict
NCT00899496 has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- 54 participants
- Enrollment target
Study Summary
RATIONALE: Studying samples of blood and tissue in the laboratory from patients with cancer and from healthy participants may help doctors learn more about cancer. PURPOSE: This laboratory study is looking at an assay in determining cancer resistance in patients with metastatic cancer and in healthy participants.
Interventions
- OTHER physiologic testing
- OTHER immunological diagnostic method
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2005-09 |
| Est. Completion | 2009-10-23 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00899496
The ClinicalTrials.gov registry entry for NCT00899496 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which physiologic testing is the first listed.
NCT00899496 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00899496 about?
NCT00899496 is a clinical study titled "Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants". RATIONALE: Studying samples of blood and tissue in the laboratory from patients with cancer and from healthy participants may help doctors learn more about cancer. PURPOSE: This laboratory study is looking at an assay in determining cancer resistance in patients with metastatic cancer and in health...
What is the current status of trial NCT00899496?
This trial is currently completed. The enrollment target is 54 participants. The study started on 2005-09. Estimated completion is 2009-10-23.
What interventions are being tested in trial NCT00899496?
The interventions under investigation include: physiologic testing (OTHER), immunological diagnostic method (OTHER).
Who is sponsoring clinical trial NCT00899496?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.